Literature DB >> 10625267

Recent advances: nephrology.

C R Tomson1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10625267      PMCID： PMC1117402          DOI： 10.1136/bmj.320.7227.98

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  43 in total

1.  Cholesterol crystal embolism: an important "new" diagnosis for the general physician.

Authors:  J M Rhodes
Journal:  Lancet       Date:  1996-06-15       Impact factor: 79.321

Review 2.  A cloned extracellular Ca(2+)-sensing receptor: molecular mediator of the actions of extracellular Ca2+ on parathyroid and kidney cells?

Authors:  E M Brown; S C Hebert
Journal:  Kidney Int       Date:  1996-04       Impact factor: 10.612

Review 3.  Origin and structure of pathogenic IgA in IgA nephropathy.

Authors:  A Allen; S Harper; J Feehally
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

Review 4.  Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney.

Authors:  S C Hebert
Journal:  Kidney Int       Date:  1996-12       Impact factor: 10.612

5.  Water channels in health and disease.

Authors:  D L Connolly; C M Shanahan; P L Weissberg
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

6.  More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.

Authors:  S Geberth; E Stier; M Zeier; G Mayer; M Rambausek; E Ritz
Journal:  J Am Soc Nephrol       Date:  1995-12       Impact factor: 10.121

7.  Progressive renal dysfunction despite successful renal artery angioplasty in a single kidney.

Authors:  A Mikhail; G J Cook; J Reidy; J E Scoble
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

8.  Risk of developing end-stage renal disease in a cohort of mass screening.

Authors:  K Iseki; C Iseki; Y Ikemiya; K Fukiyama
Journal:  Kidney Int       Date:  1996-03       Impact factor: 10.612

9.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Authors:  G Maschio; D Alberti; G Janin; F Locatelli; J F Mann; M Motolese; C Ponticelli; E Ritz; P Zucchelli
Journal:  N Engl J Med       Date:  1996-04-11       Impact factor: 91.245

Review 10.  Molecular genetics of human blood pressure variation.

Authors:  R P Lifton
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728
View more
  3 in total

Review 1.  Economic evaluation of dialysis therapies.

Authors:  Scott W Klarenbach; Marcello Tonelli; Betty Chui; Braden J Manns
Journal:  Nat Rev Nephrol       Date:  2014-08-26       Impact factor: 28.314

Review 2.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

3.  Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis.

Authors:  Tapani Salonen; Tuomo Reina; Heikki Oksa; Pekka Rissanen; Amos Pasternack
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.266
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.